Event-Driven Stocks

eFFECTOR Therapeutics, Inc.

EFTR, EFTRW

Healthcare · Healthcare · <br>Emerging growth company · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 3 warning● 3 severedetails ↓

Financials

SEC XBRL · annual
 FY23FY22FY21FY20
Revenue$0$3.6M$1.4M$42.0M
Operating income−$33.8M−$32.4M−$31.9M$15.8M
Net income−$35.8M−$22.7M$15.8M$14.2M
Total assets$20.5M$29.1M$54.1M$16.7M
Total liabilities$26.3M$25.2M$36.8M$15.7M
Equity−$5.8M$3.9M$17.3M−$132.2M
EPS (diluted)$-16.37$-13.76$0.44$0.11
Shares out.42.4M41.4M40.4M1.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2023
Operating margin
—
Net margin
—
Return on equity
618.0%
Return on assets
−174.3%
Return on capital (ROCE)
—
Liabilities / assets
128.2%
Debt / equity
—
Book value / share
$-0.14
Revenue growth (YoY)
−100.0%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2023
Altman Z″ (distress)
-41.67distress
Accruals / assets
−30.5%clean
Piotroski F-Score
1/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
30
/ 100
Profitability 50Growth 0Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 3 severe● 3 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
2 acquisitions0 disposalsnet +3,193 shares · last 2
InsiderDateTypeSharesPrice
Byrnes MichaelOfficer — Chief Financial OfficerMay 15, 2024Grant1,387$1.68
Worland Stephen TOfficer — Chief Executive OfficerMay 15, 2024Grant1,806$1.68

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.